Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan S F Chan

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Biopharmaceutical Statistics|June 23, 2004
Noninferiority and equivalence trialsIvan S F Chan
Journal of Biopharmaceutical Statistics|December 13, 2002
Power and sample size determination for noninferiority trials using an exact methodIvan S F Chan
Journal of Biopharmaceutical Statistics|December 7, 2006
Detecting qualitative interactions in clinical trials: an extension of range testJianjun Li, Ivan S F Chan
Journal of Biopharmaceutical Statistics|April 25, 2013
Determining the cutoff based on a continuous variable to define two populations with application to vaccinesShu Li, Milton Parnes, Ivan S F Chan
Journal of Biopharmaceutical Statistics|April 29, 2026
An enhanced exact permutation rank-based inferential seamless phase 2/3 designTianchen Xu, Xin Wang, Ivan S F Chan
Journal of Biopharmaceutical Statistics|June 1, 2005
Correlation coefficient inference on censored bioassay dataLiang Li, William W B Wang, Ivan S F Chan
Statistics in Medicine|November 2, 2005
Confidence interval construction for proportion difference in small-sample paired studiesMan-Lai Tang, Nian-Sheng Tang, Ivan S F Chan
Biometrics|August 21, 2003
A cautionary note on exact unconditional inference for a difference between two independent binomial proportionsDevan V Mehrotra, Ivan S F Chan, Roger L Berger
Journal of Causal Inference|January 2, 2016
Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice DefinitionPeter B Gilbert, Erin E Gabriel, Ying Huang, et al.
Contemporary Clinical Trials|July 19, 2023
A rank-based approach to improve the efficiency of inferential seamless phase 2/3 clinical trials with dose optimizationXin Wang, Min Chen, Shuyu Chu, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Biopharmaceutical Statistics|June 23, 2004
Noninferiority and equivalence trialsIvan S F Chan
Journal of Biopharmaceutical Statistics|December 13, 2002
Power and sample size determination for noninferiority trials using an exact methodIvan S F Chan
Journal of Biopharmaceutical Statistics|December 7, 2006
Detecting qualitative interactions in clinical trials: an extension of range testJianjun Li, Ivan S F Chan
Journal of Biopharmaceutical Statistics|April 25, 2013
Determining the cutoff based on a continuous variable to define two populations with application to vaccinesShu Li, Milton Parnes, Ivan S F Chan
Journal of Biopharmaceutical Statistics|April 29, 2026
An enhanced exact permutation rank-based inferential seamless phase 2/3 designTianchen Xu, Xin Wang, Ivan S F Chan
Journal of Biopharmaceutical Statistics|June 1, 2005
Correlation coefficient inference on censored bioassay dataLiang Li, William W B Wang, Ivan S F Chan
Statistics in Medicine|November 2, 2005
Confidence interval construction for proportion difference in small-sample paired studiesMan-Lai Tang, Nian-Sheng Tang, Ivan S F Chan
Biometrics|August 21, 2003
A cautionary note on exact unconditional inference for a difference between two independent binomial proportionsDevan V Mehrotra, Ivan S F Chan, Roger L Berger
Journal of Causal Inference|January 2, 2016
Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice DefinitionPeter B Gilbert, Erin E Gabriel, Ying Huang, et al.
Contemporary Clinical Trials|July 19, 2023
A rank-based approach to improve the efficiency of inferential seamless phase 2/3 clinical trials with dose optimizationXin Wang, Min Chen, Shuyu Chu, et al.
Pageof 5